# Pro-Epileptic Effects of IV Ketamine

> **NCT06741930** · PHASE4 · COMPLETED · sponsor: **Haseki Training and Research Hospital** · enrollment: 300 (actual)

## Conditions studied

- Epilepsy
- Seizure

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT06741930
- **Lead sponsor:** Haseki Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741930, "Pro-Epileptic Effects of IV Ketamine". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06741930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*